Regeneron Pharmaceuticals, Inc.
Industry / private company
Location:
Tarrytown, NY,
United States (USA) (US)
ISNI: 0000000404722713
ROR: https://ror.org/02f51rf24
Show on Map:
Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci (2023)
Han X, Gharahkhani P, Hamel AR, Ong JS, Rentería ME, Mehta P, Dong X, et al.
Journal article
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial (2020)
Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, et al.
Journal article
De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures (2019)
Horn S, Au M, Basel-Salmon L, Bayrak-Toydemir P, Chapin A, Cohen L, Elting MW, et al.
Journal article
A DREAM challenge to build prediction models for short-term discontinuation of docetaxel in metastatic castration- resistant prostate cancer (2017)
Seyednasrollah F, Wang T, Piccolo SR, Vega R, Greiner R, Fuchs C, Gofer E, et al.
Journal article
SHP2 Regulates the Osteogenic Fate of Growth Plate Hypertrophic Chondrocytes (2017)
Wang L, Huang J, Moore DC, Zuo C, Wu Q, Xie L, von der Mark K, et al.
Journal article